ADC Therapeutics (ADCT) Other Working Capital Changes: 2020-2023
Historic Other Working Capital Changes for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2023 value amounting to $13.6 million.
- ADC Therapeutics' Other Working Capital Changes was N/A to $13.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $23.0 million, marking a year-over-year change of. This contributed to the annual value of -$6.9 million for FY2024, which is 193.70% down from last year.
- ADC Therapeutics' Other Working Capital Changes amounted to $13.6 million in Q4 2023, which was up 120.24% from $6.2 million recorded in Q3 2023.
- In the past 5 years, ADC Therapeutics' Other Working Capital Changes ranged from a high of $13.6 million in Q4 2023 and a low of -$643,000 during Q1 2023.
- For the 3-year period, ADC Therapeutics' Other Working Capital Changes averaged around $2.9 million, with its median value being $1,070 (2021).
- Over the last 5 years, ADC Therapeutics' Other Working Capital Changes had its largest YoY gain of 1,265,953.17% in 2023, and its largest YoY loss of 60,275.59% in 2023.
- Over the past 4 years, ADC Therapeutics' Other Working Capital Changes (Quarterly) stood at -$4,644 in 2020, then reached $1,075 in 2021, then crashed by 199.07% to $489 in 2022, then skyrocketed by 1,265,953.17% to $13.6 million in 2023.
- Its Other Working Capital Changes stands at $13.6 million for Q4 2023, versus $6.2 million for Q3 2023 and $3.8 million for Q2 2023.